211 related articles for article (PubMed ID: 37252244)
1. Prevalence and mortality risk of low skeletal muscle mass in critically ill patients: an updated systematic review and meta-analysis.
Yang H; Wan XX; Ma H; Li Z; Weng L; Xia Y; Zhang XM
Front Nutr; 2023; 10():1117558. PubMed ID: 37252244
[TBL] [Abstract][Full Text] [Related]
2. Computed tomography-defined low skeletal muscle mass as a prognostic marker for short-term mortality in critically ill patients: A systematic review and meta-analysis.
Meyer HJ; Wienke A; Surov A
Nutrition; 2021; 91-92():111417. PubMed ID: 34399402
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Effect of Low Skeletal Muscle Mass among Hepatocellular Carcinoma Patients Undergoing Systemic Therapy: A Systematic Review and Meta-Analysis.
Kuo MH; Tseng CW; Hsu CS; Chen YC; Kao IT; Wu CY; Shao SC
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173893
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. CT-defined low-skeletal muscle mass as a prognostic marker for survival in prostate cancer: A systematic review and meta-analysis.
Meyer HJ; Wienke A; Surov A
Urol Oncol; 2022 Mar; 40(3):103.e9-103.e16. PubMed ID: 34483042
[TBL] [Abstract][Full Text] [Related]
6. The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis.
Huiskamp LFJ; Chargi N; Devriese LA; May AM; Huitema ADR; de Bree R
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33238530
[TBL] [Abstract][Full Text] [Related]
7. Impact of Low Muscle Mass on Hepatocellular Carcinoma Patients Undergoing Transcatheter Liver-Directed Therapies: Systematic Review & Meta-Analysis.
Chen YC; Kuo MH; Hsu CS; Kao IT; Wu CY; Tseng CW; Shao SC
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254808
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis.
March C; Omari J; Thormann M; Pech M; Wienke A; Surov A
Clin Nutr ESPEN; 2022 Jun; 49():103-113. PubMed ID: 35623801
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia as a predictor of mortality among the critically ill in an intensive care unit: a systematic review and meta-analysis.
Zhang XM; Chen D; Xie XH; Zhang JE; Zeng Y; Cheng AS
BMC Geriatr; 2021 Jun; 21(1):339. PubMed ID: 34078275
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors of exposure keratopathy among critically ill patients: A systematic review and meta-analysis.
Chen Y; He J; Wu Q; Pu S; Song C
Nurs Open; 2024 Jan; 11(1):e2061. PubMed ID: 38268267
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of Low-Skeletal Muscle Mass on Staging Computed Tomography in Metastasized Colorectal Cancer: A Systematic Review and Meta-Analysis.
Meyer HJ; Strobel A; Wienke A; Surov A
Clin Colorectal Cancer; 2022 Sep; 21(3):e213-e225. PubMed ID: 35792019
[TBL] [Abstract][Full Text] [Related]
12. Low skeletal muscle mass and treatment outcomes among adults with haematologic malignancies: A systematic review and meta-analysis.
Anabtawi NM; Pasala MS; Grimshaw AA; Kharel P; Bal S; Godby K; Siwakoti A; Buford TW; Bhatia S; Costa LJ; Williams GR; Giri S
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1084-1093. PubMed ID: 38558541
[TBL] [Abstract][Full Text] [Related]
13. Low Skeletal Muscle Mass Predicts Relevant Outcomes in Palliative Urological Oncology: A Systematic Review and Meta-Analysis.
Meyer HJ; Wienke A; Zamsheva M; Surov A
Urol Int; 2023; 107(3):219-229. PubMed ID: 36455534
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant micronutrient supplementation in critically ill adults: A systematic review with meta-analysis and trial sequential analysis.
Gudivada KK; Kumar A; Shariff M; Sampath S; Varma MM; Sivakoti S; Krishna B
Clin Nutr; 2021 Mar; 40(3):740-750. PubMed ID: 32723509
[TBL] [Abstract][Full Text] [Related]
15. Effect of Vitamin C on Clinical Outcomes of Critically Ill Patients With COVID-19: An Observational Study and Subsequent Meta-Analysis.
Gavrielatou E; Xourgia E; Xixi NA; Mantelou AG; Ischaki E; Kanavou A; Zervakis D; Routsi C; Kotanidou A; Siempos II
Front Med (Lausanne); 2022; 9():814587. PubMed ID: 35223911
[TBL] [Abstract][Full Text] [Related]
16. Selenium supplementation for critically ill adults.
Allingstrup M; Afshari A
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD003703. PubMed ID: 26214143
[TBL] [Abstract][Full Text] [Related]
17. Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
Kang MK; Park JG; Lee HJ; Kim MC
J Gastroenterol Hepatol; 2019 Sep; 34(9):1633-1640. PubMed ID: 30667551
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of diaphragm ultrasound to predict weaning outcome: A systematic review and meta-analysis.
Le Neindre A; Philippart F; Luperto M; Wormser J; Morel-Sapene J; Aho SL; Mongodi S; Mojoli F; Bouhemad B
Int J Nurs Stud; 2021 May; 117():103890. PubMed ID: 33588324
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia as a Prognostic Marker for Survival in Gastric Cancer Patients Undergoing Palliative Chemotherapy. A Systematic Review and Meta Analysis.
Meyer HJ; Wienke A; Surov A
Nutr Cancer; 2022; 74(10):3518-3526. PubMed ID: 35603926
[TBL] [Abstract][Full Text] [Related]
20. Computed tomography-defined body composition as prognostic markers for unfavourable outcomes and in-hospital mortality in coronavirus disease 2019.
Meyer HJ; Wienke A; Surov A
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):159-168. PubMed ID: 35018725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
